
Release date: 2026-03-11 16:56:51 Article From: Lucius Laos Recommended: 209
Common reactions include: abnormal liver function (elevated ALT/AST), anemia, decreased platelets, febrile neutropenia, diarrhea, nausea, fatigue, etc. If you experience any of these discomforts, you should contact your doctor promptly to assess whether dose adjustment is needed.
Differentiation Syndrome: Symptoms include fever, difficulty breathing, sudden weight gain, and edema. This condition can be life-threatening in severe cases and requires immediate hospitalization.
Posterior Reversible Encephalopathy Syndrome (PRES): A rare neurological issue that may cause symptoms such as seizures, headache, confusion, and visual disturbances. If these occur, stop the medication immediately and seek medical attention promptly.
QT Interval Prolongation: This can be detected through regular ECG monitoring and requires a doctor's assessment to determine if dose adjustment is necessary.
Pancreatitis: Although a direct link to the drug is not definitively established, if you experience severe upper abdominal pain, nausea, or vomiting, you should seek immediate medical attention and follow the doctor's advice to stop the medication.
Discontinue the medication in the following situations:
If differentiation syndrome does not improve after 48 hours of steroid treatment.
If symptoms suggestive of Posterior Reversible Encephalopathy Syndrome (PRES) appear.
If other severe adverse reactions occur and, after evaluation, the doctor determines that discontinuation is necessary.
Seek immediate medical attention in the following situations:
If symptoms of a serious adverse reaction worsen.
If an acute allergic reaction occurs: such as large hives on the skin, difficulty breathing, or swelling of the face or throat. These can be life-threatening and require emergency care.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643